ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Eloxx Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$12.50−0.53 (-4.07%)
Close on Oct 19, 2026
- Market cap
- $84.86M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Eloxx Pharmaceuticals has not reported a dividend
No dividend per share appears in Eloxx Pharmaceuticals's annual filings since fiscal 2009.